News

This is the first time a leading cosmetic brand and a prestigious medical institution such as Weill Cornell have collaborated on an initiative that addresses skin wellness from

The withdrawal of Tysabri after the drug was linked to a fatal brain disease, which was shortly followed by the resignation of Biogen Idec’s general counsel, has prompted

Under the terms of the agreement, Altana Pharma will supply Cyclacel with selected experimental molecules shown to interfere with mitosis (cell division). Scientists at Cyclacel’s Polgen Division in

The two companies have signed a definitive agreement under which Epimmune will combine with privately-held IDM in an all-stock transaction. By combining, Epimmune and IDM expect to create

The milestone payment comes as a result of a collaboration agreement between Icagen and Yamanouchi in dementia, including Alzheimer’s disease, which began in 2000. “A variety of ion

The clinical trial has been designed to provide further evidence that inhibiting overproduction of TNF-alpha, and other cytokines, may provide a therapeutic benefit to those suffering from AIDS.

GlaxoSmithKline’s booster vaccine candidate, Boostrix, received a unanimous favorable recommendation from the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC). If approved, Boostrix would add a pertussis

The official approval marks a significant milestone in the growth of Sinovac’s inactivated vaccines portfolio and comes as the company is nearing completion of its new production line

Accelerated approval and priority review are specific regulatory programs developed by the FDA to expedite the availability of products addressing important needs. ID Biomedical and the FDA’s Center